SEC Form 4 · accession 0001179110-17-003204

MOMENTA PHARMACEUTICALS INC · MNTA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President · Director

Period of report

Feb 22, 2017

Accepted (ET)

Feb 24, 2017 · 6:35 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001235010

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Feb 22, 2017	S	1,688	$15.51	D	305,303	D
Common Stock^F4	Feb 22, 2017	S	1,969	$15.51	D	303,334	D
Common Stock^F2	Feb 22, 2017	S	1,969	$15.51	D	301,365	D
Common Stock	holding	—	—		—	261,941	I	Craig Wheeler Revocable Trust

No Table II lines on this filing.

F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013.
F2This transaction was executed in multiple trades at prices ranging from $15.30 to $15.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2014.
F4This transaction was executed in multiple trades at prices ranging from $15.30 to $15.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2015.